July 27, 2009 - TeraRecon Inc., a leader in advanced visualization and decision support solutions for medical imaging and a partner of the Society of Cardiovascular Computed Tomography (SCCT), and Agfa HealthCare released the first cardiac CT review and reporting solution which conforms to the SCCT’s published guidelines* for cardiac CT interpretation.

The release of the integration and reporting solution was announced by Agfa HealthCare and TeraRecon on July 17th, 2009, during the well-attended Manufacturers’ Session of the SCCT’s 4th Annual Scientific Meeting, held at the Walt Disney World Dolphin Resort in Lake Buena Vista, Florida, from July 16-19, 2009.

TeraRecon’s industry-leading iNtuition cardiovascular advanced visualization tools, combined with Agfa HealthCare’s IMPAX® Cardiovascular imaging and reporting solution, provides physicians with the first cardiac CT image analysis and reporting solution that satisfies the rigorous requirements and many of the optional recommendations set forth within these guidelines.

Daniel S. Berman, MD, FSCCT of Cedars-Sinai Medical Center and immediate past-president of SCCT, explained, "Standardizing reporting helps ensure that all aspects of the studies are interpreted in a manner that will be understood by referring physicians, clearly communicating the test results."

Agfa HealthCare’s IMPAX Cardiovascular is a robust solution for cardiology and vascular imaging and reporting that consolidates and provides a single point of access for multimodality studies. It enhances communication between cardiovascular modalities, PACS and other standards-based hospital information distribution systems.

"The integration of Aquarius iNtuition with Agfa HealthCare's IMPAX Cardiovascular solution is an important step in streamlining workflow for the non-invasive cardiologist by providing a single, comprehensive solution that automates visualization and reporting. The integration with IMPAX Cardiovascular will also facilitate the communication between cardiac CT specialists and other clinicians, by making the relevant information available throughout the enterprise,” states Michael Green, Agfa HealthCare President & CEO, Agfa HealthCare - North America.

Jeff Sorenson, TeraRecon Vice President of Sales for the USA and Canada, said, “This integration and reporting capability was brought to market by Agfa HealthCare and TeraRecon less than one year after the SCCT guidelines were published; and thereby exemplifies the clear benefits of close collaboration between the scientific community and its industry partners. We continue to explore many exciting avenues to further leverage our advanced clinical tools and thin-client visualization architecture to deliver advances in clinical decision support.”

*Raff GL, Abidov A, Achenbach S, et al. SCCT guidelines for the interpretation and reporting of coronary computed tomographic angiography. Journal of Cardiovascular Computed Tomography. 2009;3:122-136.

For more information: www.scct.org/documents/SCCTGuidelinesforI&RofCCTA.pdf


Related Content

News | Artificial Intelligence

April 20, 2026 — DeepTek, provider of the Augmento platform and deepc, the company behind deepcOS, have introduced a ...

Time April 23, 2026
arrow
News | FDA

April 16, 2026 — Royal Philips has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral ...

Time April 20, 2026
arrow
News | Radiology Imaging

April 7, 2026 — Onvida Health and Siemens Healthineers have entered a 10-year Value Partnership¹ designed to bring the ...

Time April 09, 2026
arrow
News | Radiology Business

March 31, 2026 — Radon Medical Imaging, a medical imaging equipment maintenance and repair services company, has has ...

Time March 31, 2026
arrow
News | Radiology Imaging

March 26, 2026 — GE HealthCare has announced a renewed research collaboration with Stanford Medicine Department of ...

Time March 30, 2026
arrow
News | Cardiac Imaging

March 28, 2026 — When Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it ...

Time March 30, 2026
arrow
News | FDA

March 24, 2026 — MARS Bioimaging, a New Zealand–headquartered medical device company, has received U.S. Food and Drug ...

Time March 25, 2026
arrow
News | Radiology Imaging

March 23, 2026 — Samsung Medison hsa announced that its U.S. medical imaging businesses, previously operating as ...

Time March 23, 2026
arrow
News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | Lung Imaging

March 11, 2026 — Noah Medical has announced the publication of the MATCH 2 study in the international, peer-reviewed ...

Time March 12, 2026
arrow
Subscribe Now